CRT 2023

Priorities for Collaborative Efforts and Cardiogenic Shock Going Forward

Panel Moderator(s)

• 

  Ian C. Gilchrist, Sr., MD, MSCAI (he/him/his)

  Professor Of Medicine
  Penn State University/Hershey Medical Center
  Hershey, Pennsylvania, United States

  No relationships to disclose
• MM

  Mauro Moscucci, MD, MBA, MPH

  Medical Officer
  Food and Drug Administration, Center for Devices and Radiological Health, Maryland, United States

  No relationships to disclose

Panel Discussant(s)

• 

  Wayne Batchelor, MD, MHS

  Director, Interventional Cardiology and Interventional Research and Innovation
  Inova Heart & Vascular Institute
  Falls Church, Virginia, United States

  Disclosure(s): Abbott: Clinical Trial Investigator (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Idorsia Pharmaceuticals: Clinical Trial Support (Ongoing), Consultant (Ongoing); Medtronic Cardiovascular: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); V Wave: Consultant (Ongoing)
• 

  Navin K. Kapur, MD, FSCAI FAHA FACC

  Executive Director, CVCRI
  Tufts Medical Center
  Boston, Massachusetts, United States

  Disclosure information not submitted.
• 

  Ileana L. Pina, MD, MPH (she/her/hers)

  Professor of Medicine
  Thomas Jefferson University
  Cleveland hts, Ohio, United States

  Disclosure(s): boerhinger ingelheim: Advisory Committee/Board Member (Ongoing)
• 

  Eric Vang, PhD, MPH

  Vice President, Cardiac Surgery, Clinical Research and Medical Science
  Medtronic, Inc
  Mounds View, Minnesota, United States

  Disclosure information not submitted.